JP2016086744A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016086744A5 JP2016086744A5 JP2014225642A JP2014225642A JP2016086744A5 JP 2016086744 A5 JP2016086744 A5 JP 2016086744A5 JP 2014225642 A JP2014225642 A JP 2014225642A JP 2014225642 A JP2014225642 A JP 2014225642A JP 2016086744 A5 JP2016086744 A5 JP 2016086744A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- gene encoding
- genome
- viral vector
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 239000013603 viral vector Substances 0.000 claims description 7
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims description 6
- 101710169105 Minor spike protein Proteins 0.000 claims description 6
- 101710081079 Minor spike protein H Proteins 0.000 claims description 6
- 241000712079 Measles morbillivirus Species 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 3
- 230000035772 mutation Effects 0.000 claims 3
- 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 claims 2
- 101001094700 Homo sapiens POU domain, class 5, transcription factor 1 Proteins 0.000 claims 2
- 101000713275 Homo sapiens Solute carrier family 22 member 3 Proteins 0.000 claims 2
- 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 claims 2
- 102100020677 Krueppel-like factor 4 Human genes 0.000 claims 2
- 101710085938 Matrix protein Proteins 0.000 claims 2
- 101710127721 Membrane protein Proteins 0.000 claims 2
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 claims 2
- 102100024270 Transcription factor SOX-2 Human genes 0.000 claims 2
- 210000000601 blood cell Anatomy 0.000 claims 2
- 230000037430 deletion Effects 0.000 claims 2
- 238000012217 deletion Methods 0.000 claims 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 1
- 210000003071 memory t lymphocyte Anatomy 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 210000001778 pluripotent stem cell Anatomy 0.000 claims 1
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014225642A JP6854461B2 (ja) | 2014-11-05 | 2014-11-05 | ウイルスベクター、ｉＰＳ細胞の作製方法およびコンストラクト |
| EP15857426.9A EP3216868A4 (en) | 2014-11-05 | 2015-11-05 | Virus vector, cell, and construct |
| KR1020177015408A KR20200066748A (ko) | 2014-11-05 | 2015-11-05 | 바이러스 벡터, 세포 및 작제물 |
| US15/523,547 US20170304430A1 (en) | 2014-11-05 | 2015-11-05 | Virus vector, cell, and construct |
| CN201580068057.8A CN107109436A (zh) | 2014-11-05 | 2015-11-05 | 病毒载体、细胞及构建体 |
| PCT/JP2015/081145 WO2016072446A1 (ja) | 2014-11-05 | 2015-11-05 | ウイルスベクター、細胞およびコンストラクト |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014225642A JP6854461B2 (ja) | 2014-11-05 | 2014-11-05 | ウイルスベクター、ｉＰＳ細胞の作製方法およびコンストラクト |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019113463A Division JP2019170393A (ja) | 2019-06-19 | 2019-06-19 | ｉＰＳ細胞の作製方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016086744A JP2016086744A (ja) | 2016-05-23 |
| JP2016086744A5 true JP2016086744A5 (https=) | 2017-12-21 |
| JP6854461B2 JP6854461B2 (ja) | 2021-04-07 |
Family
ID=55909170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014225642A Active JP6854461B2 (ja) | 2014-11-05 | 2014-11-05 | ウイルスベクター、ｉＰＳ細胞の作製方法およびコンストラクト |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20170304430A1 (https=) |
| EP (1) | EP3216868A4 (https=) |
| JP (1) | JP6854461B2 (https=) |
| KR (1) | KR20200066748A (https=) |
| CN (1) | CN107109436A (https=) |
| WO (1) | WO2016072446A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4241853B1 (en) * | 2013-11-26 | 2026-02-11 | Zoetis Services LLC | Compositions for induction of immune response |
| CA3038721A1 (en) | 2016-09-30 | 2018-04-05 | Mayo Foundation For Medical Education And Research | Viral vectors for nuclear reprogramming |
| JP7462863B2 (ja) * | 2019-04-15 | 2024-04-08 | 国立感染症研究所長 | 組換え麻疹ウイルスの増殖方法及び宿主細胞 |
| CN110904232B (zh) * | 2019-12-12 | 2022-05-27 | 上海东方肝胆外科医院 | 评估索拉非尼疗效的分子标记及其检测试剂盒 |
| CA3244685A1 (en) * | 2021-12-28 | 2025-06-13 | Jcr Pharmaceuticals Co., Ltd. | Fusion protein of anti-transferrin receptor antibody and physiologically active protein for safe gene therapy |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS602058A (ja) | 1983-06-15 | 1985-01-08 | Mitsubishi Electric Corp | 電機子の製造方法 |
| EP1297852A4 (en) * | 2000-06-27 | 2004-12-29 | Dnavec Research Inc | VIRAL VECTOR FOR THE INTRODUCTION OF GENES IN KIDNEY CELLS (03.02.03) |
| JPWO2007007921A1 (ja) * | 2005-07-13 | 2009-01-29 | 国立大学法人九州大学 | 分節ゲノム型組換えモノネガウイルスベクター |
| WO2010008054A1 (ja) * | 2008-07-16 | 2010-01-21 | ディナベック株式会社 | 染色体非組み込み型ウイルスベクターを用いてリプログラムされた細胞を製造する方法 |
| CA2809515A1 (en) * | 2010-08-30 | 2012-03-08 | Dnavec Corporation | Composition for inducing pluripotent stem cell, and use thereof |
| JP5963309B2 (ja) * | 2010-11-09 | 2016-08-03 | 国立研究開発法人産業技術総合研究所 | 末梢血単球由来多能性幹細胞作製方法 |
| US10975358B2 (en) * | 2013-09-24 | 2021-04-13 | Id Pharma Co., Ltd. | Method for improving efficiency of inducing pluripotent stem cell |
-
2014
- 2014-11-05 JP JP2014225642A patent/JP6854461B2/ja active Active
-
2015
- 2015-11-05 CN CN201580068057.8A patent/CN107109436A/zh active Pending
- 2015-11-05 EP EP15857426.9A patent/EP3216868A4/en not_active Withdrawn
- 2015-11-05 KR KR1020177015408A patent/KR20200066748A/ko not_active Withdrawn
- 2015-11-05 WO PCT/JP2015/081145 patent/WO2016072446A1/ja not_active Ceased
- 2015-11-05 US US15/523,547 patent/US20170304430A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4659816A3 (en) | MODIFIED CAPSID PROTEINS FOR IMPROVED PARVOVIRUS VECTOR DELIVERY | |
| MX391337B (es) | Sistemas de replicón de arterivirus recombinantes y usos de estos. | |
| MX390848B (es) | Factor ix modificado, y composiciones, metodos y usos para la transferencia de genes a celulas, organos y tejidos. | |
| JP2016086744A5 (https=) | ||
| MX2016010649A (es) | Vector de virus adeno-asociado. | |
| MX2019004499A (es) | Sistemas de replicón de virus recombinante y usos de estos. | |
| MX388739B (es) | Casetes optimizados de expresión del gen humano del factor viii de coagulación y su uso. | |
| CL2019003842A1 (es) | Vectores virales recombinantes con tropismo modificado y usos de estos para la introducción dirigida de material genético a células humanas. | |
| SA517381912B1 (ar) | "عناصر تنظيمية معدلة بعد الانتساخ لعلاج الالتهاب الكبدي pre | |
| PE20160188A1 (es) | Variantes aav y composiciones, metodos y usos para transferencia de gen a celulas, organos y tejidos | |
| MX392639B (es) | Vectores virales recombinantes para la integración de transgenes | |
| EA201791343A1 (ru) | Композиции и способы для конструирования вирусного генома in vitro | |
| MX2019002938A (es) | Mutaciones estebilizantes de trimeros de proteinas de la envoltura del vih. | |
| MX2019002498A (es) | Metodos y productos para la expresion de proteinas en celulas. | |
| MX391311B (es) | Acidos nucleicos modificados dirigidos a acidos nucleicos. | |
| BR112016017736A2 (pt) | métodos e produtos para produção e distribuição de ácido nucleico | |
| BR112016025519A2 (pt) | engenharia genética in vivo com vetores de adenovírus | |
| BR112016016937A2 (pt) | Célula adaptada a suspensão isolada transduzida ou transfectada com um ácido nucleico heterólogo, porção ligada a membrana, porção ligada a membrana da célula, pluralidade de células adaptadas a suspensão isoladas, porção ligada à membrana de uma célula adaptada a suspensão isolada, partículas semelhantes a vírus ou vírus produzidas pela célula, vírus isolado, partícula semelhante a vírus isolada, pluralidade de vírus isolados, pluralidade de partículas semelhantes a vírus isoladas, ácido nucleico recombinante, células adaptadas a suspensão isoladas, célula adaptada a suspensão isolada transduzida ou transfectada com um ácido nucleico heterólogo, célula adaptada a suspensão isolada transduzida por ou transfectada com um vírus, ácido nucleico recombinante, método de identificação de um epítopo de célula t | |
| EP4043021A3 (en) | Oncolytic tumor viruses and methods of use | |
| JP2016500260A5 (https=) | ||
| DK3889166T3 (da) | Rekombinante virale vektorer, der indeholder mindre væsentlige prrsv-proteiner, og fremgangsmåder til fremstilling og anvendelse deraf | |
| EA202190469A1 (ru) | Способы оценки интегрированных нуклеиновых кислот | |
| CN109937252A (zh) | 重组dna聚合酶 | |
| MX2020013959A (es) | Mutantes de hemaglutinina del virus de la influenza. | |
| PE20170941A1 (es) | Genes de tolerancia a herbicidas y metodos para usar los mismos |